Industrial Microbiology Market by Product Type (Consumables, Equipment & Systems, Laboratory Supplies), Test Type (Bio-Burden Testing, Microbial Limits Testing, Sterility Testing), Application - Global Forecast 2024-2030
The Industrial Microbiology Market size was estimated at USD 17.06 billion in 2023 and expected to reach USD 18.41 billion in 2024, at a CAGR 8.11% to reach USD 29.46 billion by 2030.
Industrial microbiology involves the use of microorganisms for the production of industrial products in large quantities. It applies scientific and engineering principles to the processing of biological samples and materials by microorganisms to create useful products. An integral part of the bio-economy, industrial microbiology contributes to the development of new technologies and products that impact various sectors, including pharmaceuticals, food and beverages, and biofuels, among others. The demand for industrial microbiology is influenced by diverse factors, such as increasing government support for bio-based products and the growing necessity for renewable energy sources. The industry also encompasses the production of enzymes, antibiotics, and biopesticides and the process of fermentation to produce beer, wine, and cheese. However, the possibility of process contamination and the need for precise control of environmental parameters complicate industrial microbiology's production and manufacturing processes. Additionally, a lack of skilled research and technical personnel poses challenges to the optimum operation of machinery, equipment, and microbiological processes. However, manufacturers are investing efforts in imposing stringent quality control strategies and exploring the integration of advanced technologies such as AI, IoT, and robotics to reduce the chances of manual error. Furthermore, continual advancements in molecular biology, genomics, and proteomics have greatly enhanced the capabilities and applications of industrial microbiology.
Regional Insights
Industrial microbiology is well embedded in the pharmaceutical and agriculture sectors in the Americas. Major producers include the U.S. and Canada, where several multinational biotech companies are headquartered. This region has shown rapid growth due to the heavy investment in research and development. Authorities such as the Food and Drug Administration (FDA) and Health Canada are working on providing approvals for advanced industrial microbiology equipment and tests in the region. Asia holds a considerable market share in the industrial microbiology market, with the primary users being India and China, where sectors such as healthcare, food & beverages, and agriculture are major contributors. The region has seen advancements due to the increased use of biotechnological processes in manufacturing. The European region, including Germany, the UK, and France, makes substantial use of industrial microbiology, majorly in the pharmaceutical and food & beverage sectors. Investments in research & development and the presence of established biotech companies make Europe a strong player. Guidelines by the European Medicines Agency (EMA) and European Food Safety Authority (EFSA) enable the building of a safe and secure market for industrial microbiology that can cater to various industrial standards.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Industrial Microbiology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Growing production of antibiotics, drug products, and natural cosmetic ingredients
Rising concerns about waste management and government initiatives for renewable energy
Increasing consumer preference for novel and nutritionally rich food and beverage options
Market Restraints
Chances of contamination and the need for precise control of environmental parameters
Market Opportunities
Advancements and research initiatives to optimize industrial microbiology processes
Inclination towards adoption of precision agriculture for efficient crop production
Market Challenges
Limitations of machinery and process handling of industrial microbiology and lack of skilled personnel
Market Segmentation Analysis
Product: Development of advanced equipment for streamlining industrial microbiology processes
Test Type: Utilization of microbial limits testing to ensure sterility of pharmaceutical and medical products
Application: Growing sustainability and waste management concerns driving the utilization of industrial microbiology in the environmental industry
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Industrial Microbiology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Industrial Microbiology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
QIAGEN Launches Complete Sample to Insight Workflow for Microbiome Research
QIAGEN introduced its Microbiome WGS SeqSets, a comprehensive suite empowering microbiome research through a streamlined workflow from sample preparation to in-depth bioinformatic analysis. This innovation combines high-performance DNA extraction kits, sophisticated library preparation optimized for whole genome metagenomics, and advanced yet accessible bioinformatics tools. The product offers applications in varied fields, such as gut microbiology, soil ecosystem studies, and the monitoring of antibiotic resistance.
New Acquisition to Accelerate Microbiome Therapeutics Manufacture
Kanvas Biosciences acquired assets from Federation Bio, enabling the company to expedite the production and clinical investigation of intricate microbial consortia. This acquisition has facilitated the establishment of two active microbiome-based clinical programs by Kanvas to enhance its business offering.
Eppendorf Introduces the First Microcentrifuge with Hydrocarbon Cooling
Eppendorf unveiled the innovative centrifuge 5427 R, the company's microcentrifuge featuring hydrocarbon cooling technology. As the latest advancement in molecular and cell biology applications, the Centrifuge 5427 R represents an advancement in sustainable laboratory operations by integrating a refrigeration system that utilizes R290, a natural refrigerant with a minimal Global Warming Potential (GWP).
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Industrial Microbiology Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Industrial Microbiology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Asiagel Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux SA, bNovate Technologies SA, Bruker Corporation, Charles River Laboratories International, Inc., Condalab, Corning Incorporated, Cysal GmbH, Danaher Corporation, ELITechGroup Inc., Eppendorf SE, Fujifilm Holdings Corporation, HiMedia Laboratories Private Limited, HyLabs Ltd., Merck KGaA, Microbe Investigations AG, Novamed, Ltd. by Simplivia Healthcare Ltd., Qiagen N. V., Reshape ApS, Sartorius AG, Solenis LLC, Sporian Microsystems Inc., SSI Diagnostica A/S, Sysmex Corporation, Thermo Fisher Scientific Inc., and Vermicon AG.
Market Segmentation & Coverage
This research report categorizes the Industrial Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product Type
Consumables
Media
Reagents & Strains
Equipment & Systems
Air Monitoring Systems
Automated Equipment
Filtration Pumps & Systems
Incubators & Culture Apparatus
Microbial Detection Systems
Laboratory Supplies
Bags & Bottles
Filtration Disc & Membranes
Loop & Needles
Petri Dishes, Racks, Seals, Plates & Holders
Test Type
Bio-Burden Testing
Microbial Limits Testing
Sterility Testing
Water & Environmental Testing
Application
Agricultural
Cosmetic or Personal Care
Environmental
Food & Beverage
Pharmaceutical & Biotechnology
Wastewater & Sewage Treatment
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing production of antibiotics, drug products, and natural cosmetic ingredients
5.1.1.2. Rising concerns about waste management and government initiatives for renewable energy
5.1.1.3. Increasing consumer preference for novel and nutritionally rich food and beverage options
5.1.2. Restraints
5.1.2.1. Chances of contamination and the need for precise control of environmental parameters
5.1.3. Opportunities
5.1.3.1. Advancements and research initiatives to optimize industrial microbiology processes
5.1.3.2. Inclination towards adoption of precision agriculture for efficient crop production
5.1.4. Challenges
5.1.4.1. Limitations of machinery and process handling of industrial microbiology and lack of skilled personnel
5.2. Market Segmentation Analysis
5.2.1. Product: Development of advanced equipment for streamlining industrial microbiology processes
5.2.2. Test Type: Utilization of microbial limits testing to ensure sterility of pharmaceutical and medical products
5.2.3. Application: Growing sustainability and waste management concerns driving the utilization of industrial microbiology in the environmental industry
5.3. Market Trend Analysis
5.3.1. Technological advances in industrial microbiology solutions in the Americas region backed by strong presence of key players and increasing demand from developed industrial landscape
5.3.2. Potential for expansion and technology integration in the industrial microbiology sector of emerging countries in APAC, driven by the rise of sustainable practices, and availability of expertise
5.3.3. Strong R&D background of EMEA region in industrial microbiology backed by the presence of established companies and robust government initiatives to accelerate microbe usage across industries
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Industrial Microbiology Market, by Product Type
6.1. Introduction
6.2. Consumables
6.3. Equipment & Systems
6.4. Laboratory Supplies
7. Industrial Microbiology Market, by Test Type
7.1. Introduction
7.2. Bio-Burden Testing
7.3. Microbial Limits Testing
7.4. Sterility Testing
7.5. Water & Environmental Testing
8. Industrial Microbiology Market, by Application
8.1. Introduction
8.2. Agricultural
8.3. Cosmetic or Personal Care
8.4. Environmental
8.5. Food & Beverage
8.6. Pharmaceutical & Biotechnology
8.7. Wastewater & Sewage Treatment
9. Americas Industrial Microbiology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Industrial Microbiology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Industrial Microbiology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. QIAGEN Launches Complete Sample to Insight Workflow for Microbiome Research
12.3.2. New Acquisition to Accelerate Microbiome Therapeutics Manufacture
12.3.3. Eppendorf Introduces the First Microcentrifuge with Hydrocarbon Cooling